Macular Degeneration

Macular degeneration is one of the most common causes of vision loss in adults over 50, affecting millions of Americans. If you or a loved one has been diagnosed with age-related macular degeneration (AMD), understanding this condition is the first step toward managing it effectively and preserving your remaining vision.

While macular degeneration currently has no cure, significant advances in treatment can slow its progression and, in some cases, improve vision. Early detection through regular comprehensive eye exams remains the most powerful tool for protecting your sight.

What Is Macular Degeneration?

Macular degeneration is a progressive eye disease that damages the macula, the small central portion of the retina responsible for sharp, detailed vision. The retina is the light-sensitive tissue at the back of the eye that converts light into electrical signals sent to the brain. The macula, roughly the size of a pencil eraser, handles the precise central vision you need for reading, driving, recognizing faces, and seeing fine details.

When the macula deteriorates, central vision becomes blurred or distorted while peripheral (side) vision typically remains intact. This creates a unique visual experience where you can see objects in your side vision but may have difficulty seeing what's directly in front of you.

Macular degeneration primarily affects older adults, which is why it's commonly called age-related macular degeneration or AMD. The condition can develop in one or both eyes and often progresses at different rates in each eye.

Types of Macular Degeneration

AMD occurs in two forms, each with distinct characteristics and treatment approaches:

Dry (Atrophic) AMD

Dry AMD is the more common form, accounting for approximately 80-90% of all macular degeneration cases. It develops when small yellow deposits called drusen accumulate beneath the macula. Drusen are made of lipids (fatty proteins) and are a normal part of aging, but larger or numerous drusen can interfere with macular function.

As dry AMD progresses, the light-sensitive cells in the macula gradually break down, leading to slow vision loss over months or years. Some people with dry AMD never experience significant vision loss, while others progress to advanced stages that cause substantial central vision impairment.

There are three stages of dry AMD:

Early AMD: Medium-sized drusen are present, but there's typically no vision loss. Most people at this stage aren't aware they have the condition.

Intermediate AMD: Large drusen and/or pigment changes in the retina are visible. Some people notice mild symptoms, while others have no noticeable vision changes.

Advanced dry AMD (Geographic Atrophy): Breakdown of light-sensitive cells and supporting tissue in the macula causes noticeable vision loss. This stage significantly affects central vision used for reading, driving, and recognizing faces.

Wet (Neovascular) AMD

Wet AMD is less common but more serious, responsible for 90% of severe vision loss from macular degeneration. It occurs when abnormal blood vessels grow beneath the retina toward the macula. These new blood vessels are fragile and prone to leaking blood and fluid, which damages the macula rapidly.

Wet AMD can develop suddenly and cause rapid vision loss over days to weeks. Any dry AMD can progress to the wet form, which is why regular monitoring is critical for anyone diagnosed with dry macular degeneration.

The abnormal blood vessel growth in wet AMD is triggered by a protein called vascular endothelial growth factor (VEGF). Modern treatments targeting this protein have revolutionized wet AMD management and can preserve or even improve vision in many patients.

Symptoms of Macular Degeneration

Macular degeneration symptoms develop gradually, especially in the early stages of dry AMD. Many people don't notice changes until the condition has progressed significantly or affects their second eye. Recognizing these symptoms prompts earlier evaluation and treatment.

Blurred central vision: The most common early symptom. Words on a page may appear fuzzy, or you might need more light to read comfortably. The blurriness typically affects tasks requiring detailed vision, like reading, sewing, or working on a computer.

Distorted vision: Straight lines may appear wavy or bent. Door frames, telephone poles, or lines of text may look curved. This symptom, called metamorphopsia, is particularly common in wet AMD and may indicate new blood vessel growth or fluid accumulation.

Dark or empty spots: A blank or dark spot may appear in the center of your vision. This scotoma can make it difficult to see faces directly or read without moving your eyes around the page.

Difficulty adapting to low light: You may struggle to see in dim restaurants, theaters, or during evening activities. The time needed to adjust when moving from bright to dark environments increases.

Colors appear less vivid: Colors may seem faded, washed out, or less distinct from one another. This symptom develops gradually and is often noticed when comparing vision between eyes.

Difficulty recognizing faces: As central vision deteriorates, identifying people by their facial features becomes challenging, even those you know well.

Need for brighter light: Reading, writing, and close work require increasingly bright lighting to see clearly.

If you experience sudden changes in vision, especially distorted straight lines or a rapid increase in central vision blur, seek immediate medical attention. These symptoms could indicate wet AMD or other serious eye conditions requiring urgent treatment.

Causes and Risk Factors

The exact causes of macular degeneration aren't fully understood, but research has identified several factors that increase risk:

Age: The primary risk factor. AMD rarely occurs before age 50, and risk increases significantly after age 60. By age 75, the risk is substantially higher.

Genetics and family history: Having a parent or sibling with AMD significantly increases your risk. Specific genes associated with AMD have been identified, and genetic testing can help assess risk in some cases.

Smoking: Smokers are two to three times more likely to develop AMD than nonsmokers. Smoking damages blood vessels and increases oxidative stress in the eye, accelerating macular deterioration.

Race: AMD is more common in Caucasians than in other ethnic groups, though it can affect people of any race.

Cardiovascular factors: High blood pressure, high cholesterol, and obesity have been linked to increased AMD risk. Conditions affecting blood vessel health may contribute to the abnormal vessel growth seen in wet AMD.

Light exposure: Long-term exposure to blue light and UV light may contribute to AMD development, though this relationship continues to be studied.

Diet: Diets low in antioxidants, particularly lutein, zeaxanthin, vitamins C and E, and zinc, may increase risk. These nutrients help protect the macula from oxidative damage.

Understanding your risk factors helps you and your Tulsa optometrist develop an appropriate monitoring schedule and take preventive steps where possible.

How Is AMD Diagnosed?

Macular degeneration is detected through comprehensive eye examinations that evaluate the macula and retina. Early detection is critical because treatment is most effective before significant vision loss occurs.

Visual acuity testing: Standard eye chart testing measures how well you see at various distances and can detect changes in central vision clarity.

Amsler grid: This simple test uses a grid of straight lines with a central dot. You focus on the dot and note whether any lines appear wavy, missing, or distorted. The Amsler grid helps detect early macular changes and is used for at-home monitoring between appointments.

Dilated eye examination: After dilating your pupils with eye drops, your optometrist examines the retina and macula directly, looking for drusen, pigment changes, or blood vessel abnormalities.

Optical coherence tomography (OCT): This non-invasive imaging technology creates detailed cross-sectional images of the retina, showing the layers of the macula and detecting fluid accumulation or thinning of retinal tissue. OCT is essential for diagnosing wet AMD and monitoring treatment response.

Fluorescein angiography: A dye is injected into a vein in your arm and photographs are taken as the dye passes through retinal blood vessels. This test reveals leaking blood vessels characteristic of wet AMD and guides treatment decisions.

Optical coherence tomography angiography (OCTA): A newer imaging technique that visualizes blood flow in the retina without dye injection. OCTA can detect abnormal blood vessel growth in wet AMD and helps track disease progression.

Treatment Options

Treatment approaches differ significantly between dry and wet AMD. While no treatment currently reverses macular degeneration, available therapies can slow progression and, in some cases, improve vision.

Dry AMD Treatment

Currently, no medical treatments exist for early or intermediate dry AMD. Management focuses on monitoring, lifestyle modifications, and nutritional supplementation.

AREDS2 supplements: The Age-Related Eye Disease Studies (AREDS and AREDS2) demonstrated that specific nutritional supplements can reduce the risk of intermediate AMD progressing to advanced AMD by about 25%. The AREDS2 formula contains:

• Vitamin C: 500 mg
• Vitamin E: 400 IU
• Lutein: 10 mg
• Zeaxanthin: 2 mg
• Zinc: 80 mg
• Copper: 2 mg (to prevent copper deficiency from zinc)

Consult your eye doctor before starting AREDS2 supplements to confirm they're appropriate for your stage of AMD. These supplements don't prevent AMD or restore lost vision, but they can slow progression in people with intermediate or advanced disease.

Geographic atrophy treatment: In 2023, the FDA approved the first treatments specifically for geographic atrophy, the advanced form of dry AMD. These injectable medications (pegcetacoplan and avacincaptad pegol) slow the expansion of areas of geographic atrophy, though they cannot restore already-lost vision.

Wet AMD Treatment

Wet AMD requires more aggressive treatment to stop or slow abnormal blood vessel growth. Modern treatments have transformed outcomes, with many patients maintaining useful vision long-term.

Anti-VEGF injections: The primary treatment for wet AMD. These medications block vascular endothelial growth factor, the protein that stimulates abnormal blood vessel growth. Injected directly into the eye under local anesthesia, anti-VEGF drugs can stop vessel leakage, prevent new vessel formation, and sometimes improve vision.

Available anti-VEGF medications include:

• Ranibizumab (Lucentis)
• Aflibercept (Eylea)
• Bevacizumab (Avastin, off-label use)
• Brolucizumab (Beovu)
• Faricimab (Vabysmo)

Treatment typically begins with monthly injections for several months, then transitions to an individualized schedule based on response. Many patients require ongoing treatment every four to twelve weeks to maintain results.

Photodynamic therapy (PDT): Sometimes used in combination with anti-VEGF treatment. A light-sensitive drug is injected into the bloodstream and activated by a special laser directed at abnormal blood vessels. The activated drug damages these vessels while sparing surrounding tissue.

Low Vision Rehabilitation

For people who have experienced significant vision loss from AMD, low vision rehabilitation helps maximize remaining vision and maintain independence. Services may include:

• Magnifying devices for reading and close work
• Large-print books, phones, and computer screens
• Audio books and screen-reading software
• Improved lighting strategies
• Mobility training
• Counseling and support groups

Low vision specialists work with AMD patients to adapt daily activities and maintain quality of life despite central vision loss.

Prevention and Risk Reduction

While you cannot control some AMD risk factors like age and genetics, several lifestyle modifications may help protect your macula:

Don't smoke: If you smoke, quitting is the single most important step you can take to reduce AMD risk. Even long-term smokers benefit from stopping.

Eat a healthy diet: Leafy green vegetables (spinach, kale, collard greens), fish rich in omega-3 fatty acids, and colorful fruits and vegetables provide nutrients that support macular health. The AREDS2 nutrients (vitamins C and E, lutein, zeaxanthin, and zinc) are particularly important.

Exercise regularly: Physical activity supports cardiovascular health, which is linked to eye health. Regular moderate exercise may reduce AMD risk.

Maintain healthy blood pressure and cholesterol: Managing cardiovascular risk factors through diet, exercise, and medication when needed may help protect against AMD progression.

Protect your eyes from UV light: Wear sunglasses that block 100% of UV rays whenever you're outdoors. Look for lenses that also filter blue light.

Get regular eye exams: Annual comprehensive eye exams are essential for anyone over 60 or with AMD risk factors. Early detection allows for timely intervention.

Monitor your vision at home: If you've been diagnosed with AMD, use an Amsler grid daily to detect changes between appointments. Report any new distortions, dark spots, or vision changes to your eye doctor immediately.